Profile data is unavailable for this security.
About the company
MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
- Revenue in EUR (TTM)34.18k
- Net income in EUR49.70m
- Incorporated2008
- Employees1.00
- LocationMPH Health Care AGGruenauer Strasse 5BERLIN 12557GermanyDEU
- Phone+49 30 863214560
- Fax+49 30 897308669
- Websitehttps://www.mph-ag.de/en/start/
| Holder | Shares | % Held |
|---|---|---|
| CRUX Asset Management Ltd.as of 31 Mar 2022 | 8.03k | 0.19% |
| GVC Gaesco Gesti�n SGIIC SAas of 31 Dec 2023 | 3.75k | 0.09% |
| Baring Asset Management Ltd.as of 31 Oct 2022 | 3.20k | 0.08% |
| WI Verwaltungs GmbHas of 31 Dec 2022 | 3.00k | 0.07% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 17.00 | 0.00% |
